A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021;23(9):E712-720. doi:
10.1001/amajethics.2021.712.
An examination of some of the factors that can weaken the therapeutic nature of the patient-physician relationship and how a physician can resolve them in the patient's best interest.